Clinical Trial Update: A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 randomized, four-period crossover study assessing dose-response and dose-exposure of BioChaperone Insulin Lispro at three doses in adults with type 1 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BioChaperone Insulin Lispro (insulin lispro)

Snippet

Sponsor: Adocia | Conditions: Diabetes Mellitus Type 1 | Phase 2 | Status: COMPLETED